Neoplasia Flashcards
Hallmarks of cancer
self sufficiency unresponsive to inhibition signals limitless replication evasion of death evasion of immune system invasion ability reprogramming metabolism pathways
fibroma
fibrosis tissue tumor
adenoma
gland pattern in normal tumors/ tumors of gland
papilloma
finger fronds tumor on surface
cystoma
benign hollow cyst
sarcoma
solid mesenchymal tumor
leukemia
mesenchymal cells of blood
carcinoma
malignant neoplasm of epithelial tissue
mixed tumors
salivary gland tumor - pleomorphic adenoma
fibro (neoplastic)adenoma of breast
divergent differentiation
mixed tumors
teratoma
mixed tumors with more than one germ layer involvement
hamartoma
disorganized indigenous tissue
choristoma
heterotrophic rest of cells
scirrhous tumors
dense abundant fibrous desmoplasia
anaplastic cells
pleomorphic cells/giant cells large hyperchromatic nuclei/ multiple nuclei nuclear- cytoplasmic ratio - upto 1:1 (normal 1:4/1:6) coarse chromatin large nucleolus mitoses - numerous, atypical anarchic mitotic spindle tripolar/quadripolar mitotic figures abnormal orientation
dysplasia
disorderly non neoplastic proliferation
architectural anarchy
dysplasia in whole thickness of epithelium - carcinoma insitu
benign leiomyoma
no capsule
carcinoma
lymphatic spread
sarcoma
hematogenous spread
skip metastasis
papillary carcinoma of thyroid, osteosarcoma
autosomal dominant cancer syndromes
childhood retinoblastoma - tumor suppressor gene mutation
autosomal recessive syndromes of defective DNA repair
xeroderma pigmentosa
familial cancer
early onset
present in relatives
bilateral/ multiple lesions
preneoplastic lesions
metaplasia, dysplasia, hyperplasia, leukoplakia, villous adenoma, benign tumors
normal regulatory genes
protooncogenes
tumor suppressor genes
apoptosis gene
DNA repair genes
oncogenes
dominant (one allele mutation leads to- neoplasms)
tumor suppressor gene
governor - brake on proliferation
guardian - sense damage and repairing
TP53
guardian gene
loss of guardian genes like tp53
permits and accelerate mutation acquisition
balanced translocation
Burkitt lymphoma - overexpression of myc (8) on it’s translocation under Ig heavy chain regulatory element (14)
follicular B cell lymphoma - overexpression of antiapoptotic bcl2 gene (18) on its translocation under Ig heavy chain regulatory element (14)
CML- fusion gene 9-22 (Ph chromosome) leading to BCR ABL rearrangement - encode tyrosine kinase (novel chimeric protein)
Ewing sarcoma - fusion gene (t11;22) (q24;12) EWS transcription factor with Fli-1
AML, MPD
fusion genes
bcr-abl - kinase - CML
Fli-1 EWS - transcription factor ewing sarcoma
TMPRSS- ETS - transcription factor- prostate cancer
EML4 -ALK - kinase - lung carcinoma
HGMA-2 - overexpression (removal of negative regulatory microRNA site)
site of Rb gene
13q14
gene amplification
nymc - neuroblastoma
hsr - amplified gene insert into new chromosomal location
double minutes- extrachromosomal
erbb2- breast cancer
microRNA
single stranded, non coding
cleave mRNA/ repress translation
miRNA
inhibits antiapoptotic (procarcinogenic) gene bcl2
stimulate procarcinogenic RAS, MYC
miRNA
inhibits antiapoptotic (procarcinogenic) gene bcl2
stimulate procarcinogenic RAS, MYC
miRNA
inhibits antiapoptotic (procarcinogenic) gene bcl2
stimulate procarcinogenic RAS, MYC
miRNA
inhibits antiapoptotic (procarcinogenic) gene bcl2
stimulate procarcinogenic RAS, MYC
miRNA
inhibits antiapoptotic (procarcinogenic) gene bcl2
stimulate procarcinogenic RAS, MYC
miRNA
inhibits antiapoptotic (procarcinogenic) gene bcl2
stimulate procarcinogenic RAS, MYC
ECM
collagens, glycoprotein, proteoglycans
proteases in tumor invasion
mmp, cathespin D, urokinase plasminogen activator
MMP role in tumor invasion
release ECM sequestrated growth factors
remodel basement membrane
mmp 9 gelatinase
cleave type iv collagen
release vegf
direct acting chemical carcinogen
alkylating agents - leukemia
indirectly acting chemical carcinogens
benzopyrene active principle- epoxide aromatic amines azo dyes beta naphthylamine - bladder cancer aflatoxin - hepatocellular carcinoma nitrites
metabolic activation by monooxygenases (polymorphism)
aflatoxin
signature mutation in tp53
TAX gene in HTLV-1 virus
activate genes - of cytokines (il2, 15), receptors, costimulatory factors
bind to cyclins
t cell mitogens - polyclonal proliferation
finally tp53 - tumor suppressors- monoclonal neoplasms
Paraneoplastic endocrinopathy
small cell lung carcinoma
pancreatic and neural carcinoma
SIADH Paraneoplastic
small cell lung carcinoma, intracranial tumor
hyperglycaemia
squamous cell carcinoma of lung
breast, renal, adult t cell leukemia/lymphoma, ovarian
hypoglycemia
fibrosarcoma
mesenchymal sarcoma
hepatocellular carcinoma
Paraneoplastic carcinoid syndrome
bronchial adenoma
pancreatic, gastric carcinoma
polycythemia Paraneoplastic
renal carcinoma
cerebellar hemangioma
hepatocellular carcinoma
(erythropoietin)
myasthenia Paraneoplastic
bronchogenic carcinoma
thymoma
myasthenia Paraneoplastic
bronchogenic carcinoma
thymoma
disorders of cns and pns
breast Cancer
teratomas
acanthosis nigricans Paraneoplastic
gastric adenoma
lung and uterine carcinoma
dermatomyositis
bronchogenic
breast cancer
hypertrophy osteoarthropathy, clubbing of fingers
bronchogenic carcinoma
venous thrombosis
pancreatic, bronchogenic carcinoma
non bacterial endocarditis
advanced cancer
anemia
thymoma
NEPHROTIC syndrome
Paraneoplastic syndrome
in various cancers
cytokeratin
undifferentiated carcinoma
CEA
colon , pancrease, stomach, breast carcinoma